Mucosal healing in inflammatory bowel disease: Maintain or de-escalate therapy.

about

In vivo analysis of mucosal lipids reveals histological disease activity in ulcerative colitis using endoscope-coupled Raman spectroscopy Insights on the use of biosimilars in the treatment of inflammatory bowel disease.

P2860

Q33901644-C66790A2-998F-4F0B-B4EB-1EAE7BAF4684 Q38735477-7BE8A666-DDA2-470A-A267-D542B4693A28

P2860

Mucosal healing in inflammatory bowel disease: Maintain or de-escalate therapy.

Item

http://www.wikidata.org/entity/Q36578893

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

2016年论文

@zh

2016年论文

@zh-cn

name

Mucosal healing in inflammatory bowel disease: Maintain or de-escalate therapy.

@ast

Mucosal healing in inflammatory bowel disease: Maintain or de-escalate therapy.

@en

type

Item

label

Mucosal healing in inflammatory bowel disease: Maintain or de-escalate therapy.

@ast

Mucosal healing in inflammatory bowel disease: Maintain or de-escalate therapy.

@en

prefLabel

Mucosal healing in inflammatory bowel disease: Maintain or de-escalate therapy.

@ast

Mucosal healing in inflammatory bowel disease: Maintain or de-escalate therapy.

@en

P1476

Mucosal healing in inflammatory bowel disease: Maintain or de-escalate therapy

@en

P2093

Giuseppe Costantino

http://www.w3.org/2001/XMLSchema#string

Marcello Cintolo

http://www.w3.org/2001/XMLSchema#string

Socrate Pallio

http://www.w3.org/2001/XMLSchema#string

P2860

Increasing Incidence and Prevalence of the Inflammatory Bowel Diseases With Time, Based on Systematic Review

A simple method for assessing intestinal inflammation in Crohn's disease

Withdrawal of anti-tumour necrosis factor α therapy in inflammatory bowel disease

Treating beyond symptoms with a view to improving patient outcomes in inflammatory bowel diseases

The physiological structure of human C-reactive protein and its complex with phosphocholine

Oral versus combination mesalazine therapy in active ulcerative colitis: a double-blind, double-dummy, randomized multicentre study.

Developing an instrument to assess the endoscopic severity of ulcerative colitis: the Ulcerative Colitis Endoscopic Index of Severity (UCEIS)

Adalimumab induces and maintains mucosal healing in patients with Crohn's disease: data from the EXTEND trial.

Preliminary case-control study to evaluate diagnostic values of C-reactive protein and erythrocyte sedimentation rate in differentiating active Crohn's disease from intestinal lymphoma, intestinal tuberculosis and Behcet's syndrome.

Predictability of the postoperative course of Crohn's disease.

P304

1-16

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

editorial

P356

10.4291/WJGP.V7.I1.1

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Walter Fries

P577

2016-02-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

292387080

http://www.w3.org/2001/XMLSchema#string

P698

26909224

http://www.w3.org/2001/XMLSchema#string

P921

inflammatory bowel diseases

P932

4753175

http://www.w3.org/2001/XMLSchema#string

Mucosal healing in inflammatory bowel disease: Maintain or de-escalate therapy.

about

P2860

P2860

Mucosal healing in inflammatory bowel disease: Maintain or de-escalate therapy.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P5875

P698

P921

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P5875

P698

P921

P932